ReviewCurrent gastroenterology reports2015
Implementing quality measures for inflammatory bowel disease.
Review in Current gastroenterology reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it.
- ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease.The American journal of gastroenterology · 2017Guideline
- Understanding clinician connections to inform efforts to promote high-quality inflammatory bowel disease care.PloS one · 2022Article
- Metric Development for the Multicenter Improving Pediatric Sepsis Outcomes (IPSO) Collaborative.Pediatrics · 2021Article
- Improving Quality in the Care of Patients with Inflammatory Bowel Diseases.Inflammatory bowel diseases · 2018Review
- Quality indicators in inflammatory bowel disease.Intestinal research · 2018Review
- Bridges to excellence quality indicators in inflammatory bowel disease (IBD): differences between IBD and non-IBD gastroenterologists.Annals of gastroenterology · 2017Article
- Variation in Care of Inflammatory Bowel Diseases Patients in Crohn's and Colitis Foundation of America Partners: Role of Gastroenterologist Practice Setting in Disease Outcomes and Quality Process Measures.Inflammatory bowel diseases · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Variation in care for inflammatory bowel disease (IBD) is present across multiple aspects of IBD management, suggesting overall poor quality of care. Quality indicators are intended to provide clear, measurable processes and outcomes of quality care. Initial sets of process and outcome measures have been developed to address areas of inconsistent care and to allow for standardized measurement of outcomes. Measures developed by the Crohn's and Colitis Foundation of America (CCFA) are intended to provide measurable standards for improvement in care. These measure sets will warrant updates overtime to best represent gaps in IBD management. Practically, implementation of quality measures may depend on the care setting and whether quality measurement and improvement can be incorporated into workflows and electronic medical records. Collaborative networks, utilization of care pathways, and standardized treatment algorithms may represent avenues for wide-scale implementation of quality improvement. Implementation efforts should assess the impact on outcomes in order to identify successful models for improvement in IBD care.
Indexed as
Identifiers
25762473What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.